| 1 |
Litak J, Mazurek M, Kulesza B, et al. Cerebral small vessel disease [J]. Int J Mol Sci, 2020, 21(24): 9729.
|
| 2 |
Puy L, Pasi M, Rodrigues M, et al. Cerebral microbleeds: from depiction to interpretation [J]. J Neurol Neurosurg Psychiatry, 2021: jnnp-2020-323951.
|
| 3 |
彭斌. 脑小血管病研究进展 [J/OL]. 中华脑血管病杂志(电子版), 2025, 19(4): 352.
|
| 4 |
田成林, 蒲传强. 脑微出血患者的抗栓治疗:一个两难选择 [J]. 中华神经科杂志, 2014, 47(11): 745-756.
|
| 5 |
Greenberg SM. Cerebral microbleeds and prediction of intracranial haemorrhage [J]. Lancet Neurol, 2021, 20(4): 252-254.
|
| 6 |
Fanou EM, Coutinho JM, Shannon P, et al. Critical illness-associated cerebral microbleeds [J]. Stroke, 2017, 48(4): 1085-1087.
|
| 7 |
Wrigley S, Cody R, Amadoru S, et al. Prevalence and associations of cerebral microbleeds in an Australian Memory clinic cohort [J]. Intern Med J, 2025, 55(4): 608-616.
|
| 8 |
Hussein AS, Shawqi M, Bahbah EI, et al. Do cerebral microbleeds increase the risk of dementia? A systematic review and Meta-analysis [J]. IBRO Neurosci Rep, 2023, 14: 86-94.
|
| 9 |
Charidimou A, Kakar P, Fox Z, et al. Cerebral microbleeds and recurrent stroke risk: systematic review and Meta-analysis of prospective ischemic stroke and transient ischemic attack cohorts [J]. Stroke, 2013, 44(4): 995-1001.
|
| 10 |
Wang DN, Hou XW, Yang BW, et al. Quantity of cerebral microbleeds, antiplatelet therapy, and intracerebral hemorrhage outcomes: a systematic review and Meta-analysis [J]. J Stroke Cerebrovasc Dis, 2015, 24(12): 2728-2737.
|
| 11 |
胡红梅, 胡文立. 不同空间分布脑微出血的常见病因和影像学特征的研究进展 [J/OL]. 中华脑血管病杂志(电子版), 2022, 16(1): 8-11.
|
| 12 |
Pasi M, Charidimou A, Boulouis G, et al. Mixed-location cerebral hemorrhage/microbleeds: underlying microangiopathy and recurrence risk [J]. Neurology, 2018, 90(2): e119-e126.
|
| 13 |
Sousanidou A, Tsiptsios D, Christidi F, et al. Exploring the impact of cerebral microbleeds on stroke management [J]. Neurol Int, 2023, 15(1): 188-224.
|
| 14 |
Wadi LC, Grigoryan MM, Kim RC, et al. Mechanisms of cerebral microbleeds [J]. J Neuropathol Exp Neurol, 2020, 42(2): 1093-1099.
|
| 15 |
Gyanwali B, Shaik MA, Tan CS, et al. Mixed-location cerebral microbleeds as a biomarker of neurodegeneration in a memory clinic population [J]. Aging (Albany NY), 2019, 11(22): 10581-10596.
|
| 16 |
张蓉, 赵晨阳, 何志义. 不同影像学表现的脑小血管病所致认知障碍特点的研究进展 [J/OL]. 中华脑血管病杂志(电子版), 2022, 16(1): 44-47.
|
| 17 |
Wang G, Estrella A, Hakim O, et al. Mini-mental state examination and montreal cognitive assessment as tools for following cognitive changes in Alzheimer's disease neuroimaging initiative participants [J]. J Alzheimers Dis, 2022, 90(1): 263-270.
|
| 18 |
Patnode CD, Perdue LA, Rossom RC, et al. Screening for Cognitive Impairment in Older Adults: An Evidence Update for the U.S. Preventive Services Task Force [M]. Rockville (USA): Agency for Healthcare Research and Quality, 2020: Ⅳ-Ⅴ, 6, 23, 59, 70.
|
| 19 |
Hou M, Hou X, Qiu Y, et al. Characteristics of cognitive impairment and their relationship with total cerebral small vascular disease score in Parkinson's disease [J]. Front Aging Neurosci, 2022, 14: 884506.
|
| 20 |
Zhu R, Li Y, Chen L, et al. Total burden of cerebral small vessel disease on MRI may predict cognitive impairment in Parkinson's disease [J]. J Clin Med, 2022, 11(18): 5381.
|
| 21 |
Raulin AC, Doss SV, Trottier ZA, et al. ApoE in Alzheimer's disease: pathophysiology and therapeutic strategies [J]. Mol Neurodegener, 2022, 17(1): 72.
|
| 22 |
Greenberg SM, Rebeck GW, Vonsattel JP, et al. Apolipoprotein E epsilon 4 and cerebral hemorrhage associated with amyloid angiopathy [J]. Ann Neurol, 1995, 38(2): 254-259.
|
| 23 |
Brouwers HB, Biffi A, Ayres AM, et al. Apolipoprotein E genotype predicts hematoma expansion in lobar intracerebral hemorrhage [J]. Stroke, 2012, 43(6): 1490-1495.
|
| 24 |
Tsai HH, Chen SJ, Tsai LK, et al. Long-term vascular outcomes in patients with mixed location intracerebral hemorrhage and microbleeds [J]. Neurology, 2021, 96(7): e995-e1004.
|
| 25 |
Fandler-Höfler S, Obergottsberger L, Ambler G, et al. Association of the presence and pattern of MRI markers of cerebral small vessel disease with recurrent intracerebral hemorrhage [J]. Neurology, 2023, 101(8): e794-e804.
|
| 26 |
Schneck MJ, Biller J. Antithrombotic therapy in patients with cerebral microbleeds or cortical siderosis: is this contraindicated? [J]. Neurology, 2023, 100(12): 551-552.
|
| 27 |
Wilson D, Werring DJ. Antithrombotic therapy in patients with cerebral microbleeds [J]. Curr Opin Neurol, 2017, 30(1): 38-47.
|
| 28 |
Wang Y, Wang Y, Zhao X, et al. Clopidogrel with aspirin in acute minor stroke or transient ischemic attack [J]. N Engl J Med, 2013, 369(1): 11-19.
|
| 29 |
Kleindorfer DO, Towfighi A, Chaturvedi S, et al. 2021 guideline for the prevention of stroke in patients with stroke and transient ischemic attack: a guideline from the American Heart Association/American Stroke Association [J]. Stroke, 2021, 52(7): e364-e467.
|
| 30 |
Soo YO, Yang SR, Lam WW, et al. Risk vs benefit of anti-thrombotic therapy in ischaemic stroke patients with cerebral microbleeds [J]. J Neurol, 2008, 255(11): 1679-1686.
|
| 31 |
Meng N, Zhang W, Su Y, et al. Antiplatelet therapy may be safe in ischemic stroke patients with cerebral microbleed [J]. J Int Med Res, 2020, 48(8): 300060520949396.
|
| 32 |
中华人民共和国国家卫生健康委员会. 脑血管病防治指南(2024年版) [J]. 磁共振成像, 2025, 16(1): 1-8.
|
| 33 |
Fu H, Ge L, Liang J. Cerebral microbleeds and antiplatelet therapy in Mongolian and Han patients with ischemic cerebrovascular disease [J]. J Multidiscip Healthc, 2024, 17: 5789-5798.
|
| 34 |
Cong D, Qi W, Liu X, et al. Pharmacokinetic study of enteric-coated sustained-release aspirin tablets in healthy Chinese participants [J]. Drug Des Devel Ther, 2023, 17: 2421-2429.
|
| 35 |
Sun K, Liu H. Emerging biomarkers and frontier therapies: unveiling the role of endothelial dysfunction in cerebral small vessel disease [J]. Front Neurol, 2025, 16: 1615883.
|
| 36 |
中华医学会神经病学分会, 中华医学会神经病学分会脑血管病学组. 中国脑小血管病诊治指南2020 [J]. 中华神经科杂志, 2022, 55(8): 807-818.
|
| 37 |
Yılmaz H, Bayraktutan U. Cerebral small vessel disease: therapeutic approaches targeting neuroinflammation, oxidative stress, and endothelial dysfunction [J]. Curr Issues Mol Biol, 2025, 47(4): 232.
|
| 38 |
Guo Y, Li Y, Liu X, et al. Assessing the effectiveness of statin therapy for alleviating cerebral small vessel disease progression in people ≥75 years of age [J]. BMC Geriatr, 2020, 20(1): 292.
|